Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation
Hypoxia-induced inflammation is the critical pathological feature of acute kidney injury (AKI). Activation of hypoxia-inducible factor (HIF) signaling is considered as a central mechanism of body adapting to hypoxia. Hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 (Roxadustat) is a fir...
Main Authors: | A-Feng Miao, Jian-Xiang Liang, Lei Yao, Jun-Ling Han, Li-Juan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/0886022X.2021.1915801 |
Similar Items
-
Prolyl hydroxylase inhibitor FG-4592 alleviates neuroinflammation via HIF-1/BNIP3 signaling in microglia
by: Qianqian Ruan, et al.
Published: (2024-04-01) -
Roxadustat (FG-4592) Facilitates Recovery From Renal Damage by Ameliorating Mitochondrial Dysfunction Induced by Folic Acid
by: Xue Li, et al.
Published: (2022-02-01) -
Roxadustat (FG-4592) abated lipopolysaccharides-induced depressive-like symptoms via PI3K signaling
by: Axiang Li, et al.
Published: (2023-03-01) -
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
by: Xuan Li, et al.
Published: (2018-04-01) -
FG-4592 protects the intestine from irradiation-induced injury by targeting the TLR4 signaling pathway
by: Zhenlan Feng, et al.
Published: (2022-06-01)